JOHN HINTON: Open Payments
NPI 1982649182 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 22 payments from 6 companies in 2025. Trend: 2023 $594 · 2024 $459 · 2025 $607
Food & beverage: $407Speaker / faculty: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $299 |
| UCB, Inc. | 2 | $227 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Amgen Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $13 |
Products named: Zilbrysq, BOTOX, QULIPTA, AMVUTTRA, Briviact, Symbravo, KESIMPTA, UBRELVY.
Industry payments across AL — which companies pay providers there.
